CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Holds a degree in Biomedicine (2005) and Pharmacy (2006) from the Methodist University of São Paulo, with a Master's degree (2011) and a Doctorate in Sciences (2014), focusing on molecular biology and hematology from the University of São Paulo. Has experience in Medicine, with emphasis on Clinical Research, where he was coordinator of clinical research for 7 years, conducting studies in onco hematology (Leukemias, Lymphomas and Myeloma) and neuromuscular diseases. In the pharmaceutical field, he worked in novartis medical for 8 years, as medical science liaison and medical manager for molecules related to chronic and acute leukemias, myelofibrosis, polycythenaemia vera, host exerto disease and lymphoma. He was responsible for the implementation of the first clinical study in Brazil with CAR-T cells, also being technical responsible for the internal biosafety commission (CQB). He is currently the medical leader of Kite Pharma, responsible for the implementation of the portfolio of cell therapy and CAR-T in Brazil. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Chronic myeloid leukemia (CML) is a clonal expansion of the hematopoietic progenitor cell, representing myeloid hyperplasia, leukocytosis, neutrophilia, basophilia and splenomegaly. The Philadelphia chromosome is peculiar on the disease, being the result of the translocation t(9; 22) (q34; q11), leading on the fusion of the ABL and BCR genes. This merger creates a hybrid gene that produce…
| 3 / 1 | Completed scholarships in Brazil |
| Associated processes | |